These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

451 related articles for article (PubMed ID: 28540648)

  • 1. Impact of 2015 Update to the Beers Criteria on Estimates of Prevalence and Costs Associated with Potentially Inappropriate Use of Antimuscarinics for Overactive Bladder.
    Suehs BT; Davis C; Ng DB; Gooch K
    Drugs Aging; 2017 Jul; 34(7):535-543. PubMed ID: 28540648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Potentially Inappropriate Use of Antimuscarinic Medications on Healthcare Use and Cost in Individuals with Overactive Bladder.
    Suehs BT; Davis C; Franks B; Yuran TE; Ng D; Bradt J; Knispel J; Vassilakis M; Berner T
    J Am Geriatr Soc; 2016 Apr; 64(4):779-87. PubMed ID: 27059714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimated Budget Impact of Increased Use of Mirabegron, A Novel Treatment for Overactive Bladder.
    Perk S; Wielage RC; Campbell NL; Klein TM; Perkins A; Posta LM; Yuran T; Klein RW; Ng DB
    J Manag Care Spec Pharm; 2016 Sep; 22(9):1072-84. PubMed ID: 27579830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using the Beers criteria to identify potentially inappropriate medication use by older adult dental patients.
    Skaar DD; O'Connor H
    J Am Dent Assoc; 2017 May; 148(5):298-307. PubMed ID: 28284416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of potentially inappropriate medications among the Lithuanian elderly according to Beers and EU(7)-PIM list - a nationwide cross-sectional study on reimbursement claims data.
    Grina D; Briedis V
    J Clin Pharm Ther; 2017 Apr; 42(2):195-200. PubMed ID: 28155237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potentially Inappropriate Prescribing in Disabled Older Patients with Chronic Diseases: A Screening Tool of Older Persons' Potentially Inappropriate Prescriptions versus Beers 2012 Criteria.
    Yang PJ; Lee YT; Tzeng SL; Lee HC; Tsai CF; Chen CC; Chen SC; Lee MC
    Med Princ Pract; 2015; 24(6):565-70. PubMed ID: 26279164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimuscarinic use among older adults with dementia and overactive bladder: a Medicare beneficiaries study.
    Kachru N; Holmes HM; Johnson ML; Chen H; Aparasu RR
    Curr Med Res Opin; 2021 Aug; 37(8):1303-1313. PubMed ID: 33890538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Costs of potentially inappropriate medication use in residential aged care facilities.
    Harrison SL; Kouladjian O'Donnell L; Milte R; Dyer SM; Gnanamanickam ES; Bradley C; Liu E; Hilmer SN; Crotty M
    BMC Geriatr; 2018 Jan; 18(1):9. PubMed ID: 29325531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of inappropriate medication prescription in the elderly in Nigeria: A comparison of Beers and STOPP criteria.
    Fadare JO; Desalu OO; Obimakinde AM; Adeoti AO; Agboola SM; Aina FO
    Int J Risk Saf Med; 2015; 27(4):177-89. PubMed ID: 26756891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing the prevalence of Beers medication utilization in the Medicare Part D population in 2020.
    Borrelli EP
    J Am Geriatr Soc; 2024 Sep; 72(9):2800-2806. PubMed ID: 38709112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular morbidity, heart rates and use of antimuscarinics in patients with overactive bladder.
    Andersson KE; Sarawate C; Kahler KH; Stanley EL; Kulkarni AS
    BJU Int; 2010 Jul; 106(2):268-74. PubMed ID: 19922546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimuscarinic Discontinuation in Patients with Overactive Bladder in Nursing Homes: A Retrospective Study of Medicare Beneficiaries.
    Aparasu RR; Sura S; Earla JR; Shiozawa A; Ng DB; Schermer CR
    Adv Ther; 2020 Aug; 37(8):3584-3605. PubMed ID: 32638205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potentially inappropriate medications in hospitalized older patients: a cross-sectional study using the Beers 2015 criteria versus the 2012 criteria.
    Zhang X; Zhou S; Pan K; Li X; Zhao X; Zhou Y; Cui Y; Liu X
    Clin Interv Aging; 2017; 12():1697-1703. PubMed ID: 29066875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of adaptive versions of the Hong Kong-specific criteria and 2015 Beers criteria for assessing potentially inappropriate medication use in Hong Kong older patients.
    Zhang H; Wong ELY; Wong SYS; Chau PYK; Yip BHK; Chung RYN; Lee EKP; Lai FTT; Yeoh EK
    BMC Geriatr; 2021 Jun; 21(1):379. PubMed ID: 34154544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potentially Inappropriate Medications Are Associated with Increased Healthcare Utilization and Costs.
    Clark CM; Shaver AL; Aurelio LA; Feuerstein S; Wahler RG; Daly CJ; Jacobs DM
    J Am Geriatr Soc; 2020 Nov; 68(11):2542-2550. PubMed ID: 32757494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prescription of potentially inappropriate medication in Korean older adults based on 2012 Beers Criteria: a cross-sectional population based study.
    Nam YS; Han JS; Kim JY; Bae WK; Lee K
    BMC Geriatr; 2016 Jun; 16():118. PubMed ID: 27255674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive Validity of the Beers and Screening Tool of Older Persons' Potentially Inappropriate Prescriptions (STOPP) Criteria to Detect Adverse Drug Events, Hospitalizations, and Emergency Department Visits in the United States.
    Brown JD; Hutchison LC; Li C; Painter JT; Martin BC
    J Am Geriatr Soc; 2016 Jan; 64(1):22-30. PubMed ID: 26782849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of three different sets of explicit criteria for assessing inappropriate prescribing in older patients: a nationwide prevalence study of ambulatory care visits in Taiwan.
    Chang CB; Yang SY; Lai HY; Wu RS; Liu HC; Hsu HY; Hwang SJ; Chan DC
    BMJ Open; 2015 Nov; 5(11):e008214. PubMed ID: 26546136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of potentially inappropriate medications and risk of adverse clinical outcome in a cohort of hospitalized elderly patients: results from the REPOSI Study.
    Pasina L; Djade CD; Tettamanti M; Franchi C; Salerno F; Corrao S; Marengoni A; Marcucci M; Mannucci PM; Nobili A;
    J Clin Pharm Ther; 2014 Oct; 39(5):511-5. PubMed ID: 24845066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Healthcare resource use and costs of privately insured patients who switch, discontinue, or persist on anti-muscarinic therapy for overactive bladder.
    Ivanova JI; Hayes-Larson E; Sorg RA; Birnbaum HG; Berner T
    J Med Econ; 2014 Oct; 17(10):741-50. PubMed ID: 25051328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.